Histogenics' IPO

Histogenics raised a round of funding on December 03, 2014. Investors include Public.

Histogenics is a regenerative medicine company that combines cell therapy and tissue engineering technologies to develop products for tissue repair and regeneration. Histogenics' flagship product…

Articles about Histogenics' IPO: